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Neonatal subgaleal hematomas (SGHs) are infrequent
but may be underdiagnosed collections of blood
beneath the galea, often caused by vacuum delivery.
With massive bleeding into the subgaleal space, exsan-
guination and hypovolemic shock have caused death
in 20–60% of newborn infants [1]. SGHs are mostly
caused by vacuum delivery, and sometimes by neona-
tal coagulopathy. We report a case of a newborn who
suffered from severe SGHs and anemia on the third
day after delivery.
A 26-year-old, gravida 1, para 0, mother, who had
regular prenatal care at our hospital with no abnormal
laboratory data or abnormal sonographic findings, was
admitted to our delivery room at 38 weeks’ gestation
for labor. The first and second stages of labor took
about 15 hours and 6 hours, respectively. Vacuum extrac-
tion was used because of maternal exhaustion and
prolonged second stage. Third-degree perineal lacera-
tion was found after delivery. The male baby was
active and irritable after delivery, with Apgar scores of
9 and 10 at 1 and 5 minutes, respectively. A small caput
succedaneum occurred as usual, on the posterior
fontanel. Unfortunately, the caput succedaneum seemed
to progress until a big cephalohematoma was noted on
the third day of delivery. It crossed the midline (sagittal
suture) and covered the whole occipital area down
towards the posterior neck, even though we packed it
with an elastic cap. It continued to grow toward the
anterior neck region and then the cheek. Patches of
ecchymosis were noted over the eyelids (Figure), ante-
rior neck, and ears. Because of this unusual appearance,
the complete blood count was checked and revealed
an anemic and coagulopathy status (red blood cells
1.81 × 106/μL; hemoglobin 6.8 g/dL; hematocrit 19.5%;
platelet 337 × 103/μL; activated partial thromboplas-
tin time > 200 seconds). The factor IX assay decreased
markedly to 1.1%. Brain ultrasound was arranged, and
it showed no obvious intracranial hemorrhaging or
lesions.
The hematoma and hemorrhaging seemed to be
established after the blood transfusion with packed
red blood cells of 60 mL, and resolution was noted 
10 days after delivery. Thus, under the impression of
factor IX deficiency, we sent the blood sample to the
National Taiwan University Medical Center where the
diagnosis was confirmed. The baby fed well and no neu-
rologic deficits were noted after delivery. Unfortunately,
the patient and her baby were lost to follow-up after
discharge.
Hemophilia B is a deficiency in the clotting factor IX.
It is an X-linked recessive coagulation disorder, which
occurs in one out of every 25,000–30,000 male births
and requires even rarer genetic circumstances for phe-
notypic expression in females [1]. It presents as the
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Figure. Ecchymosis over both eyelids.
impairment of blood clotting ability and prolonged
bleeding time. The outcomes are good with early 
treatment and management.
The severity of hemophilia B symptoms depends on
how a particular gene abnormality affects the activity of
the factor IX. When the activity is less than 1% of nor-
mal, episodes of prolonged bleeding may occur for no
apparent reason. Severity of symptoms can vary, but
severe forms become apparent soon after birth. Pro-
longed bleeding is the disease’s hallmark. Additional
bleeding manifestations make their appearance when
the infant becomes mobile. People whose clotting activ-
ity is 5% of normal may have only mild hemophilia. They
rarely have unprovoked bleeding episodes, but surgery
or injury may cause uncontrolled bleeding, which can
be fatal (1.1% of infants suffered from severe subgaleal
hematomas after the instrumental delivery, like our
case). Milder hemophilia may not be diagnosed at 
all, although some people, whose clotting activity is
10–25% of normal, may bleed excessively after surgery,
dental extractions or major injuries.
Neonatal SGHs are diagnosed when collections of
blood are noted beneath the galea, which are often
caused by vacuum delivery [2]. It is a rare but poten-
tially lethal condition found in newborns. Optimizing
the outcomes for babies with SGH requires early diag-
nosis, careful monitoring, and prompt treatment.
Diagnosis is made by history taking and physical exam-
ination. Monitoring includes a minimum of 8 hours of
observation for all babies following difficult vacuum
extractions or forceps deliveries, regardless of Apgar
scores or need for resuscitation. This observation should
include at least hourly recording of vital signs. Exami-
nation of the head, including the circumference of the
head and assessment of the location and characteris-
tics of any swelling, should be repeated hourly if con-
cerns are present. The presence of fluctuance early on,
whether or not the swelling is progressive, is an impor-
tant distinguishing feature of SGH. Because blood
spreads through a large tissue plane, blood loss may
be massive before hypovolemia becomes evident (as in
our case).
When SGH is suggested, hemoglobin measurements
should be performed as soon as possible and should
be monitored every 4–8 hours, as should coagulation
studies [2]. Kilani and Wetmore [3] revealed the pre-
sentations and outcomes of 34 infants with SGHs,
and the mortality rate was 11.8%. Those who died had
significant volume loss with anemia, coagulopathy and
shock, requiring large volumes of blood and blood
product transfusions. The presence of intracranial hem-
orrhage did not correlate with the severity of SGH or
death, but the severity of SGH correlates with death.
Minor neurologic abnormalities were noted in only
11% of infants [3]. For the treatment of SGHs, Amar 
et al [4] presented two cases of neonatal SGHs, who
had radiographic features indicative of elevated intra-
cranial pressure as well as neurologic decompensation.
The first patient received scalp incision initially, and the
second patient was too unstable for operative interven-
tion and died. This surgical evacuation of neonatal SGH
has not been described previously. Extracranial cerebral
compression represents another way by which neona-
tal SGH may jeopardize the infant’s life. Management
should consist of measures to correct hypovolemic shock
and disseminated intravascular coagulation, as well as
surgical intervention to control elevated intracranial
pressure [4].
In our case, neither parents had obvious family his-
tory of bleeding. Hemophilia or other bleeding and
clotting disorders were suggested, as there may be
marked hematoma from delivery, especially after a
vacuum extraction. For the diagnosis of hemophilia B,
there are several laboratory abnormalities, such as
prolongation of activated partial thromboplastin time
(variable with degree of hemophilia), decreased factor
IX activity, and normal bleeding time and thrombin
time. In addition, imaging of the central nervous system
may be in order, especially when there have been neuro-
logic signs. Once the defect has been identified, other
family members will need less testing to diagnose the
disorder.
Hemophilia B is typically treated by infusing the
missing clotting factor. The amount infused depends
upon the severity of bleeding, the site of the bleeding,
and the size of the patient. A hepatitis B vaccine is rec-
ommended for individuals with hemophilia B, because
they are at increased risk of developing hepatitis due to
exposure to blood products. During a bleeding episode,
more clotting factors are needed. To prevent a bleed-
ing crisis, people with hemophilia and their families
can be taught to administer factor IX concentrates at
home at the first signs of bleeding. People with severe
forms of the disease may need regular prophylaxis
infusions two to three times a week.
Both parents of the child with hemophilia should
receive genetic counseling. A woman who gives birth
to a child with hemophilia often has other male relatives
who also have hemophilia. Sometimes, a baby will be
born with hemophilia when there is no known family
history. This means that either the gene has been “hid-
den” (i.e. passed down through several generations of
female carriers without affecting any male members of
the family) or the change in the X chromosome is new
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(a “spontaneous mutation”). All daughters of a man
with hemophilia will be carriers, and none of his sons
will have hemophilia. Unfortunately, the parents of
this baby were lost to follow-up after delivery.
Neonatal coagulopathy is not common, but it
should be alerted when abnormal progression of
cephalohematoma to subgaleal hematoma after instru-
mental delivery or even after spontaneous delivery is
observed. Early management is necessary for good out-
comes. Genetic counseling for the parents should be car-
ried out in order to determine the risks of hemophilia
in the future.
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